Optimal Designs for Two-Arm, Phase II Clinical Trial Design with Multiple Constraints-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimal Designs for Two-Arm, Phase II Clinical Trial Design with Multiple Constraints

Published:2009-12-31 Issue:1 Volume:20 Page:106-124
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Mayo Matthew S.¹²,Mahnken Jonathan D.¹²,Soong Seng-jaw³

Affiliation:

1. a Department of Biostatistics , University of Kansas Medical Center , Kansas City , Kansas , USA

2. b Center for Biostatistics and Advanced Informatics , University of Kansas Medical Center , Kansas City , Kansas , USA

3. c Biostatistics & Bioinformatics Unit , University of Alabama at Birmingham , Birmingham , Alabama , USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543400903280597

Reference19 articles.

1. Optimal Allocation for the Comparison of Proportions

2. Optimal allocation for Bayesian inference about an odds ratio

3. Minimization of sample size when comparing two small probabilities in a non-inferiority safety trial

4. Power evaluation of small drug and vaccine experiments with binary outcomes

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bayesian Optimal Phase II Design for Randomized Clinical Trials;STAT BIOPHARM RES;2022

2. Bayesian Optimal Phase II Design for Randomized Clinical Trials;Statistics in Biopharmaceutical Research;2022-04-21

3. Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP);Clinical Cancer Research;2020-11-18

4. Bayesian design for two-arm randomized Phase II clinical trials with endpoints from the exponential family using multiple constraints;Journal of Biopharmaceutical Statistics;2017-11-27

5. Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion family;Pharmaceutical Statistics;2016-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3